Scratching, rubbing, chewing, licking. All signs of an irritated, itchy dog. With approximately 17 million U.S. dogs ...

A newly published study compared clinical outcomes of Zenrelia and another leading JAK inhibitor, plus the latest faces of ...

Elanco Animal Health Inc. (NYSE:ELAN), a leading player in the animal health industry with a market capitalization of $5.95 billion, has been navigating a complex landscape of product launches, ...

Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease ...

Elanco Animal Health Incorporated (NYSE:ELAN) has also recently received US FDA approvals for two significant products. Zenrelia is a JAK inhibitor for treating pruritus and atopic dermatitis in ...